Literature DB >> 20538045

Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity.

Y Zhang1, E Rodrigues, Y X Gao, M King, K Y Cheng, B Erdös, N Tümer, C Carter, P J Scarpace.   

Abstract

Short-term pharmacological melanocortin activation deters diet-induced obesity (DIO) effectively in rodents. However, whether central pro-opiomelanocortin (POMC) gene transfer targeted to the hypothalamus or hindbrain nucleus of the solitary track (NTS) can combat chronic dietary obesity has not been investigated. Four-weeks-old Sprague-Dawley rats were fed a high fat diet for 5 months, and then injected with either the POMC or control vector into the hypothalamus or NTS, and body weight and food intake recorded for 68 days. Insulin sensitivity, glucose metabolism and adrenal indicators of central sympathetic activation were measured, and voluntary wheel running (WR) assessed. Whereas the NTS POMC-treatment decreased cumulative food consumption and caused a sustained weight reduction over 68 days, the hypothalamic POMC-treatment did not alter cumulative food intake and produced weight loss only in the first 25 days. At death, only the NTS-POMC rats had a significant decrease in fat mass. They also displayed enhanced glucose tolerance, lowered fasting insulin and increased QUICK value, and elevated adrenal indicators of central sympathetic activation. Moreover, the NTS-POMC animals exhibited a near 20% increase in distance ran relative to the respective controls, but the ARC-POMC rats did not. In conclusion, POMC gene transfer to the NTS caused modest anorexia, persistent weight loss, improved insulin sensitivity, and increased propensity for WR in DIO rats. These metabolic improvements may involve stimulation of energy expenditure via centrally regulated sympathetic outflow. The similar POMC treatment in the hypothalamus had minimal long-term physiological or metabolic impact. Thus, melanocortin activation in the brainstem NTS region effectively ameliorates chronic dietary obesity whilst that in the hypothalamus fails to do so. (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538045      PMCID: PMC2924636          DOI: 10.1016/j.neuroscience.2010.06.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

Review 1.  CNS melanocortin system involvement in the regulation of food intake.

Authors:  S Benoit; M Schwartz; D Baskin; S C Woods; R J Seeley
Journal:  Horm Behav       Date:  2000-06       Impact factor: 3.587

2.  Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance.

Authors:  Yi Zhang; Michael Matheny; Nihal Tümer; Philip J Scarpace
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

3.  The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation.

Authors:  D L Williams; J M Kaplan; H J Grill
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

4.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Authors:  S B Heymsfield; A S Greenberg; K Fujioka; R M Dixon; R Kushner; T Hunt; J A Lubina; J Patane; B Self; P Hunt; M McCamish
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

5.  Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Authors:  A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

6.  The central melanocortin system can directly regulate serum insulin levels.

Authors:  W Fan; D M Dinulescu; A A Butler; J Zhou; D L Marks; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

7.  Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat.

Authors:  M J Hansen; M J Ball; M J Morris
Journal:  Brain Res       Date:  2001-02-16       Impact factor: 3.252

8.  Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II.

Authors:  Philip J Scarpace; Michael Matheny; Sergei Zolotukhin; Nihal Tümer; Yi Zhang
Journal:  Neuropharmacology       Date:  2003-08       Impact factor: 5.250

9.  Effect of exercise on mRNA expression of select adrenal medullary catecholamine biosynthetic enzymes.

Authors:  S Remzi Erdem; Haydar A Demirel; Christopher S Broxson; Bistra B Nankova; Esther L Sabban; Nihal Tümer
Journal:  J Appl Physiol (1985)       Date:  2002-08

10.  Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.

Authors:  Toshiro Kishi; Carl J Aschkenasi; Charlotte E Lee; Kathleen G Mountjoy; Clifford B Saper; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2003-03-10       Impact factor: 3.215

View more
  14 in total

Review 1.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

2.  Stimulation of the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating polypeptide induces hypophagia and thermogenesis.

Authors:  Jon M Resch; Joanne P Boisvert; Allison E Hourigan; Christopher R Mueller; Sun Shin Yi; Sujean Choi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

Review 3.  Melanocortin control of energy balance: evidence from rodent models.

Authors:  Bart C De Jonghe; Matthew R Hayes; Kendra K Bence
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

4.  Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiency.

Authors:  Bart C De Jonghe; Matthew R Hayes; Derek J Zimmer; Scott E Kanoski; Harvey J Grill; Kendra K Bence
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

5.  Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.

Authors:  I Côté; Y Sakarya; N Kirichenko; D Morgan; C S Carter; N Tümer; P J Scarpace
Journal:  Can J Physiol Pharmacol       Date:  2016-10-19       Impact factor: 2.273

6.  Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice.

Authors:  Eric D Berglund; Claudia R Vianna; Jose Donato; Mi Hwa Kim; Jen-Chieh Chuang; Charlotte E Lee; Danielle A Lauzon; Peagan Lin; Laura J Brule; Michael M Scott; Roberto Coppari; Joel K Elmquist
Journal:  J Clin Invest       Date:  2012-02-13       Impact factor: 14.808

7.  Brainstem nutrient sensing in the nucleus of the solitary tract inhibits feeding.

Authors:  Clemence Blouet; Gary J Schwartz
Journal:  Cell Metab       Date:  2012-11-07       Impact factor: 27.287

8.  Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.

Authors:  Katrina Weston-Green; Xu-Feng Huang; Chao Deng
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  Unacylated ghrelin suppresses ghrelin-induced neuronal activity in the hypothalamus and brainstem of male rats [corrected].

Authors:  Darko M Stevanovic; Aldo Grefhorst; Axel P N Themmen; Vera Popovic; Joan Holstege; Elize Haasdijk; Vladimir Trajkovic; Aart-Jan van der Lely; Patric J D Delhanty
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

Review 10.  Role of oxytocin signaling in the regulation of body weight.

Authors:  James E Blevins; Jacqueline M Ho
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.